Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study

Wendy Lim, MD, Mark Crowther, MD, Luqi Wang, James D. Douketis, MD, Terri Schnurr, Cathy Moreau, Catherine Clase, Marc Rodger, MD MSc, FRCPC, Erik Yeo, MD, Martine Leblanc, Philip McFarlane, Christine M. Ribic, MD

Blood (2016) 128 (22): 90.

https://doi.org/10.1182/blood.V128.22.90.90

Published: 2016

Journal Articles

Efficacy and Safety of Weight-Adjusted Extended Duration Tinzaparin for Prevention of Post-Operative Venous Thromboembolism after Bariatric Surgery

Deborah M. Siegal, MD MSc, Pankaj Handa, MD, Emma Kolesar, Mehran Anvari, MD, Maria Tiboni, MD, James D. Douketis, MD, Mark A. Crowther, MD MSc, FRCPC

Blood (2015) 126 (23): 1130.

https://doi.org/10.1182/blood.V126.23.1130.1130

Published: 2015

Journal Articles

Risk Factors Predictive of Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism

Ryma Ihaddadene, BHSc, MSc, Daniel J Corsi, PhD, Alejandro Lazo-Langner, MD, Sudeep Shivakumar, MD, Vicky Tagalakis, MD MSc, Ryan Zarychanski, MD MSc, Susan Solymoss, MD, Nathalie Routhier, MD, James D. Douketis, MD, Marc Carrier, MD MSc

Blood (2015) 126 (23): 625.

https://doi.org/10.1182/blood.V126.23.625.625

Published: 2015

Journal Articles

Positive Predictive Value of Progressively Elevated D-Dimer Levels in Patients with a Suspected First Deep Vein Thrombosis.

Sarah Louise Dunbar Takach Lapner, MD, Lori Ann Linkins, MD, MSc, Shannon M. Bates, MD, Jim Julian, MSc, James D. Douketis, MD, Sameer Parpia, Sam Schulman, MD, PhD, Clive Kearon, MD, PhD, for The SELECT Investigators

Blood (2012) 120 (21): 2258.

https://doi.org/10.1182/blood.V120.21.2258.2258

Published: 2012

Journal Articles

Venous Thromboembolism Validation Study of the IMPROVE Risk Assessment Models in the Medical Patient (VTE-VALOURR),

Charles Edward Mahan, III, PharmD, Yang Liu, M Math, James D. Douketis, MD, Alexander G.G. Turpie, Undaleeb Dairkee, MD, Alex C Spyropoulos, MD

Blood (2011) 118 (21): 4218.

https://doi.org/10.1182/blood.V118.21.4218.4218

Published: 2011

Journal Articles

Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score

Alberto Tosetto, M.D., Alfonso Iorio, Maura Marcucci, Trevor Baglin, MD, Mary Cushman, MD, MSc, Sabine Eichinger, MD, Gualtiero Palareti, Daniela Poli, MD, Campbell R Tait, James D. Douketis, MD

Blood (2011) 118 (21): 544.

https://doi.org/10.1182/blood.V118.21.544.544

Published: 2011

Journal Articles

Safety of Excluding Suspected Deep Vein Thrombosis with a Single Whole-Leg Compression Ultrasound: Systematic Review and Meta-Analysis.

Stacy A Johnson, MD, Scott M Stevens, MD, Scott C Woller, MD, Erica Lake, MLS, Marco Donadini, MD, James D Douketis, MD, FRCP

Blood (2009) 114 (22): 243.

https://doi.org/10.1182/blood.V114.22.243.243

Published: 2009

Journal Articles

Risk Factors for Bleeding in Patients with Nonvalvular Atrial Fibrillation Who Are Receiving Anticoagulant Therapy with Ximelagatran or Warfarin: Findings from the SPORTIF III and V Trials.

James D. Douketis, MD, FRCP (C), Karin Arneklev, MSc, Samuel Goldhaber, MD, John Spandorfer, MD, Frank Halperin, MD, Jay Horrow, MD, MS, FAHA

Blood (2004) 104 (11): 528.

https://doi.org/10.1182/blood.V104.11.528.528

Published: 2004

Journal Articles

Ximelagatran Versus Warfarin: A Comparison of Bleeding Outcomes in Patients with Nonvalvular Atrial Fibrillation.

James D. Douketis, MD, FRCP(C), Karin Arneklev, MSc, Samuel Goldhaber, MD, John Spandorfer, MD, Frank Halperin, MD, Jay Horrow, MD, MS, FAHA

Blood (2004) 104 (11): 1765.

https://doi.org/10.1182/blood.V104.11.1765.1765

Published: 2004

Journal Articles

Enoxaparin Is Effective and Safe as Bridging Anticoagulation in Patients with a Mechanical Prosthetic Heart Valve who Require Temporary Interruption of Warfarin because of Surgery or an Invasive Procedure.

Alexander G. Turpie, MD, James D. Douketis, MD

Blood (2004) 104 (11): 703.

https://doi.org/10.1182/blood.V104.11.703.703

Published: 2004

NARROW

Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study

Efficacy and Safety of Weight-Adjusted Extended Duration Tinzaparin for Prevention of Post-Operative Venous Thromboembolism after Bariatric Surgery

Risk Factors Predictive of Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism

Positive Predictive Value of Progressively Elevated D-Dimer Levels in Patients with a Suspected First Deep Vein Thrombosis.

Venous Thromboembolism Validation Study of the IMPROVE Risk Assessment Models in the Medical Patient (VTE-VALOURR),

Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score

Safety of Excluding Suspected Deep Vein Thrombosis with a Single Whole-Leg Compression Ultrasound: Systematic Review and Meta-Analysis.

Risk Factors for Bleeding in Patients with Nonvalvular Atrial Fibrillation Who Are Receiving Anticoagulant Therapy with Ximelagatran or Warfarin: Findings from the SPORTIF III and V Trials.

Ximelagatran Versus Warfarin: A Comparison of Bleeding Outcomes in Patients with Nonvalvular Atrial Fibrillation.

Enoxaparin Is Effective and Safe as Bridging Anticoagulation in Patients with a Mechanical Prosthetic Heart Valve who Require Temporary Interruption of Warfarin because of Surgery or an Invasive Procedure.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only